최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Fitoterapia, v.83 no.8, 2012년, pp.1532 - 1539
Liu, W. , Tian, R. , Hu, W. , Jia, Y. , Jiang, H. , Zhang, J. , Zhang, L.
The main object of this work is to prepare self-microemulsifying drug delivery system (SMEDDS) for oral bioavailability enhancement of a poorly water-soluble drug, baicalein. SMEDDS is the mixture of surfactants, cosurfactants, and oils, which are emulsified in aqueous media under conditions of gent...
Toxicol Appl Pharmacol Chiu 255 316 2011 10.1016/j.taap.2011.07.008 Baicalein inhibits the migration and invasive properties of human hepatoma cells
Environ Toxicol Pharmacol Lee 31 233 2011 10.1016/j.etap.2010.11.002 Mitochondria protection of baicalein against oxidative damage via induction of manganese superoxide dismutase
J Food Sci Lee 75 H212 2010 10.1111/j.1750-3841.2010.01755.x Evaluation of antioxidant and inhibitory activities for different subclasses flavonoids on enzymes for rheumatoid arthritis
Exp Biol Med (Maywood) Ling 236 851 2011 10.1258/ebm.2011.010395 Baicalein potently suppresses angiogenesis induced by vascular endothelial growth factor through the p53/Rb signaling pathway leading to G1/S cell cycle arrest
Biochim Biophys Acta Takahashi 1813 1465 2011 10.1016/j.bbamcr.2011.05.003 Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells
Pharm Res Amidon 12 413 1995 10.1023/A:1016212804288 A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability
Biol Pharm Bull Lai 26 79 2003 10.1248/bpb.26.79 Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans
J Pharm Pharmacol Lai 55 205 2003 10.1211/002235702522 Comparison of metabolic pharmacokinetics of baicalin and baicalein in rats
Pharm Res Zhang 22 1050 2005 10.1007/s11095-005-5303-7 Role of intestinal first-pass metabolism of baicalein in its absorption process
Med Res Rev Gautam 29 767 2009 10.1002/med.20156 Recent developments in anti-inflammatory natural products
Cancer Treat Rev Li-Weber 35 57 2009 10.1016/j.ctrv.2008.09.005 New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin
Xenobiotica Srinivas 40 357 2010 10.3109/00498251003663724 Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives
Int J Pharm Liu 312 137 2006 10.1016/j.ijpharm.2006.01.011 Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin
AAPS PharmSciTech He 12 104 2011 10.1208/s12249-010-9560-3 Comparison of spray freeze drying and the solvent evaporation method for preparing solid dispersions of baicalein with Pluronic F68 to improve dissolution and oral bioavailability
Int J Pharm Zhang 420 180 2011 10.1016/j.ijpharm.2011.08.023 Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal
Int J Pharm Kang 274 65 2004 10.1016/j.ijpharm.2003.12.028 Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs
Int J Pharm Liu 365 136 2009 10.1016/j.ijpharm.2008.08.009 Optimization and in situ intestinal absorption of self-microemulsifying drug delivery system of oridonin
Drug Dev Ind Pharm Wang 37 1225 2011 10.3109/03639045.2011.565774 Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems
Drug Dev Ind Pharm Wu 37 15 2011 10.3109/03639045.2010.489560 Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability
Drug Dev Ind Pharm Venkatesh 36 735 2010 10.3109/03639040903460446 In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone
Curr Drug Deliv Patel 6 419 2009 10.2174/156720109789000519 Self micro-emulsifying drug delivery system: formulation development and biopharmaceutical evaluation of lipophilic drugs
Adv Colloid Interface Sci Spernath 128-130 47 2006 10.1016/j.cis.2006.11.016 Microemulsions as carriers for drugs and nutraceuticals
Drug Dev Ind Pharm Patel 33 1318 2007 10.1080/03639040701385527 Oral bioavailability enhancement of acyclovir by self-microemulsifying drug delivery systems (SMEDDS)
Pharmazie Patel 66 124 2011 Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis
Pharm Res Zhang 24 81 2007 10.1007/s11095-006-9126-y Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein
Life Sci Xing 78 140 2005 10.1016/j.lfs.2005.04.072 Absorption and enterohepatic circulation of baicalin in rats
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.